Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1503)	1/13/2006 2:22:37 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

ZVXI Continues its upmove without closing the Nov.2 upgap.<g> bigcharts.marketwatch.com The stock has gained more than 300% since then and is now trading above its March 2000 H of 14.44 bigcharts.marketwatch.com ZVXI had a 344% improvement on earnings on the last Q on a 52% improvement on revenues and the 4thQ results are also expected to show significant improvement from the 2004 results.<g>. Bernard

To: Jibacoa who wrote (1503)	3/16/2007 12:32:45 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

PCYC Is up 10%. The insiders have done some recent buying in spite of the Feb 21 DG.<g> bigcharts.marketwatch.com It has been able to trim some of its losses in the last 4Qs. but it is expected to remain on the red in 2007 & 2008. Its Xcytrin has completed a PIII & is on other PI & PII alone or in combination with chemo and/or radiation for treatment in various types of Cas.It also has other product candidates, including compounds it acquired from CRA. The stock trades around 1.7xBV. Insiders reportedly hold >10% & institutions > 20% PCYC Feb 2000 H was 86 <g> bigcharts.marketwatch.com Bernard